Fig. 1From: Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialSchedule of enrolment, interventions, and assessments {12}{13}. *Sputum tests can be repeated at the baseline visit if needed for eligibility assessmentBack to article page